At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Prospective Evaluation of Four Injectable Neuromodulators in the Glabella Area
In Brief
A clinical study evaluating Onabotulinumtoxina for Injection, Abobotulinumtoxina for Injection, and 2 other interventions for Cosmetic Techniques. Completed, enrolled 143 participants across 1 site.
Detailed Summary
The purpose of the study is to use 3D imaging to evaluate the effects of four FDA approved neuromodulators on facial lines, wrinkles and animation. Participation is available to women who have never had a cosmetic procedure above the malar region nor a treatment with a neuromodulator within 12 months. All subjects will undergo 3D imaging using the VECTRA M3 (Canfield Scientific, Inc, Fairfield, NJ) prior to treatment with a neuromodulator in order to determine their baseline dimensions. Imaging will be repeated post injection to determine change over time.
Study Details
Timeline
Interventions
cosmetic injection into the glabella area (eyebrow area)
cosmetic injection into the glabella area (eyebrow area)
cosmetic injection into the glabella area (eyebrow area)
cosmetic injection into the glabella area (eyebrow area)